IEZZI, ANNALISA
 Distribuzione geografica
Continente #
NA - Nord America 466
EU - Europa 384
AS - Asia 217
SA - Sud America 14
AF - Africa 1
Totale 1.082
Nazione #
US - Stati Uniti d'America 463
CN - Cina 73
SG - Singapore 69
UA - Ucraina 67
SE - Svezia 53
IE - Irlanda 52
FR - Francia 51
IT - Italia 48
GB - Regno Unito 45
TR - Turchia 44
DE - Germania 25
IN - India 24
FI - Finlandia 20
BR - Brasile 14
RU - Federazione Russa 10
BE - Belgio 7
HK - Hong Kong 4
CZ - Repubblica Ceca 3
CA - Canada 1
CR - Costa Rica 1
IL - Israele 1
IQ - Iraq 1
JP - Giappone 1
KE - Kenya 1
MX - Messico 1
NL - Olanda 1
NO - Norvegia 1
PL - Polonia 1
Totale 1.082
Città #
Chandler 91
Jacksonville 66
Dublin 52
Singapore 49
Ann Arbor 44
Ashburn 28
New York 26
Southend 26
Princeton 22
Izmir 20
The Dalles 19
Chieti 18
Beijing 13
Nanjing 12
Wilmington 12
Cambridge 11
Woodbridge 11
Altamura 10
Nanchang 10
Dearborn 9
Washington 9
Brussels 7
Santa Clara 7
Boardman 6
Kunming 6
Los Angeles 6
Munich 5
Tianjin 5
Turku 5
Grevenbroich 4
Hefei 4
Helsinki 4
Hong Kong 4
Foggia 3
Hangzhou 3
Hebei 3
Moscow 3
Pescara 3
San Mateo 3
Auburn Hills 2
Brno 2
Guangzhou 2
Hanover 2
Lanzhou 2
Rio de Janeiro 2
Rome 2
San Salvo 2
Seattle 2
Tortoreto 2
Apodaca 1
Atlanta 1
Baghdad 1
Belo Horizonte 1
Buffalo 1
Chongqing 1
Curitiba 1
Harbin 1
Heredia 1
Imperatriz 1
Jiaxing 1
Jinan 1
Leawood 1
Marabá Municipality 1
Milan 1
Mogi Guaçu 1
Morro Agudo 1
Mumbai 1
Nairobi 1
Nanning 1
Nanyang 1
Ningbo 1
Norwalk 1
Nova Iguaçu 1
Nuremberg 1
Orange 1
Paris 1
Pedreiras 1
Penne 1
Pirapora do Bom Jesus 1
Pontedera 1
Prague 1
Recife 1
Richmond 1
San Francisco 1
Shenyang 1
Shijiazhuang 1
São José do Rio Preto 1
São Sebastião do Paraíso 1
Taizhou 1
Tokyo 1
Warsaw 1
Zhengzhou 1
Totale 702
Nome #
Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes. 123
Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques. 122
Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteases activity 109
Association between prostaglandin E receptor subtype EP4 overexpression and unstable phenotype in atherosclerotic plaques in human. 104
Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. 104
A Polymorphism in the Cyclooxygenase 2 Gene as an Inherited Protective Factor Against Myocardial Infarction and Stroke 102
Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty. 101
Association between 5-lipoxygenase expression and plaque instability in humans. 97
Relationship between reduced BCL-2 expression in circulating mononuclear cells and early nephropathy in type 1 diabetes. 86
Enhanced soluble CD40 Ligand is responsible for endothelial dysfunction and monocyte activation in patients with diabetes mellitus. Effect of improved metabolic control. 78
COX-2: friend or foe? 75
Totale 1.101
Categoria #
all - tutte 4.641
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.641


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202020 0 0 0 0 0 0 0 0 0 0 16 4
2020/202192 12 0 14 1 8 20 2 0 13 13 1 8
2021/202268 3 1 2 12 6 2 4 1 6 8 8 15
2022/2023220 15 34 12 33 25 41 8 8 34 2 5 3
2023/2024124 5 3 13 1 9 57 20 3 3 3 0 7
2024/2025175 14 34 20 5 8 12 2 4 21 20 35 0
Totale 1.101